Evidence map›Paper›PMID 40436311›Full record

ArticleThe Journal of investigative dermatology2026

Cutibacterium Adaptation to Life on Humans Provides a Potential C acnes Infection Biomarker.

Md Shafiuddin, Wen-Chi Huang, Gabriel William Prather, Jeffrey Ryan Anton, Andrew Lawrence Martin, Sydney Brianna Sillart, Jonathan Z Tang, Michael R Vittori, Michael J Prinsen, Jessica Jane Ninneman and 5 more

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Characterisation of the NovelInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

15 authors.

Md ShafiuddinDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Wen-Chi HuangDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Gabriel William PratherDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Jeffrey Ryan AntonDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Andrew Lawrence MartinDivision of Biology & Biomedical Sciences, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Sydney Brianna SillartWashington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Jonathan Z TangWashington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Michael R VittoriWashington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Michael J PrinsenHigh-Throughput Screening Center, Center for Drug Discovery, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Jessica Jane NinnemanDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Chandrashekhara ManithodyDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Jeffrey P HendersonDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Alexander W AleemDepartment of Orthopedic Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Ma Xenia Garcia IlaganHigh-Throughput Screening Center, Center for Drug Discovery, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
William H McCoyDivision of Dermatology, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA. Electronic address: mccoyw@wustl.edu.

Funding

Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Mechanistic Investigations of Sebaceous Skin Microbial Community Remodeling in Acne RemissionK08AR076464 · NIAMS · WASHINGTON UNIVERSITY · PI MCCOY IV, WILLIAM HOWARD · 2020 to 2024
$796k
NCATS NIH HHS KL2 TR002346NIAMS NIH HHS K08 AR076464
6 · The paper itself

Abstract

Propionibacteriaceae appear to have adapted to life on humans during the domestication of cattle. These microbial immigrants formed the genus Cutibacterium, and a descendent of those microbial trailblazers (C acnes) now dominates 25% of human skin. C acnes colonization of human skin requires the protein RoxP. Although all Cutibacteria encode this adaptation to life on humans, nothing like RoxP has been found in any other organism. In this study, we report an extensive assessment of 21 RoxP orthologs, which identified conserved molecular surfaces linked to heme-dependent oligomerization and low pH stability. Our investigation suggests how RoxP helps C acnes dominate sebaceous skin, and it identified an ortholog associated with the emergence of an acne vulgaris-associated, pathobiont subspecies. C acnes is also an emerging pathogen that frequently infects joint prostheses and other medical devices. These infections are often missed, because there is no test to confirm a C acnes infection. To address this clinical need, we developed immunoassays that can assess RoxP in human biofluids commonly infected by C acnes. This study's findings and assays will help shed light on the consequences of Neolithic Age livestock domestication, the evolution of skin commensals into pathogens, and how to identify infections of human "replacement parts."

Indexed as

Acne VulgarisAdaptation, PhysiologicalBacterial ProteinsGram-Positive Bacterial InfectionsPropionibacteriaceaePropionibacterium acnesSkinAnimalsBiomarkersCattleHumansBacterial ProteinsBiomarkersAcneHemePropionibacteriumProsthesisRoxP

Identifiers

PMID40436311
PMCPMC13244789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.